APA (7th ed.) Citation

Mu, F., Cai, Z., Du, L., Zeng, X., Zhou, Q., Chen, Y., & Wang, F. (2025). Efficacy and safety of recombinant human granulocyte colony-stimulating factor in patients with unexplained recurrent pregnancy loss: A protocol for a multicenter, randomized, double-blind, controlled trial. Current controlled trials in cardiovascular medicine, 26(1), 245-13. https://doi.org/10.1186/s13063-025-08951-2

Chicago Style (17th ed.) Citation

Mu, Fangxiang, Zhuhua Cai, Lirong Du, Xianghui Zeng, Qi Zhou, Yaolong Chen, and Fang Wang. "Efficacy and Safety of Recombinant Human Granulocyte Colony-stimulating Factor in Patients with Unexplained Recurrent Pregnancy Loss: A Protocol for a Multicenter, Randomized, Double-blind, Controlled Trial." Current Controlled Trials in Cardiovascular Medicine 26, no. 1 (2025): 245-13. https://doi.org/10.1186/s13063-025-08951-2.

MLA (9th ed.) Citation

Mu, Fangxiang, et al. "Efficacy and Safety of Recombinant Human Granulocyte Colony-stimulating Factor in Patients with Unexplained Recurrent Pregnancy Loss: A Protocol for a Multicenter, Randomized, Double-blind, Controlled Trial." Current Controlled Trials in Cardiovascular Medicine, vol. 26, no. 1, 2025, pp. 245-13, https://doi.org/10.1186/s13063-025-08951-2.